Show Summary Details
Page of

Infections in haematopoietic stem cell transplant recipients 

Infections in haematopoietic stem cell transplant recipients
Infections in haematopoietic stem cell transplant recipients

Simon M. Fox

, Angela M. Minassian

, Thomas Rawlinson

, and Brian J. Angus

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 13 July 2020

Haematopoietic stem cell transplantation (HSCT) has a central role in the treatment of a variety of benign and malignant diseases. The major causes of early morbidity and mortality are disease relapse, acute graft-versus-host disease (GvHD), regimen-related toxicity, graft failure, and infection. Long-term survivors of HSCT are at risk of a variety of long-term adverse effects, including chronic GvHD, endocrine disturbances, disease relapse, second malignancy, and, again, infection. The incidence of and types of infection that can develop vary with time since transplantation, different sources of stem cells, different preparative regimens, different types of immunosuppression, comorbidities, and whether the individual experiences chronic GvHD.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.